What is IPCL and what does it correct?

IPCL is an implantable contact lens treatment method that corrects myopia and astigmatism by inserting a small lens into the eye.

What material is used for the IPCL lens according to the article?

The IPCL lens uses an acrylic polymer material primarily composed of HEMA, which is also used in intraocular lenses for cataracts.

Why is the IPCL treatment considered highly reversible compared to LASIK?

It is highly reversible because it does not involve shaving the cornea, allowing the lens to be removed from the eye in the future.

When did IPCL receive regulatory approval in Japan and when was it launched?

IPCL obtained regulatory approval in April 2025 and was subsequently launched in September 2025 in Japan.

What percentage of the survey subjects were aware of implantable contact lenses?

According to the survey results, more than 70% (72.8%) of the survey subjects were aware of this treatment method.

AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 50/100

AI Summary (NQ-processed)

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is IPCL and what does it correct?: A: IPCL is an implantable contact lens treatment method that corrects myopia and astigmatism by inserting a small lens into the eye.
Q: What material is used for the IPCL lens according to the article?: A: The IPCL lens uses an acrylic polymer material primarily composed of HEMA, which is also used in intraocular lenses for cataracts.
Q: Why is the IPCL treatment considered highly reversible compared to LASIK?: A: It is highly reversible because it does not involve shaving the cornea, allowing the lens to be removed from the eye in the future.
Q: When did IPCL receive regulatory approval in Japan and when was it launched?: A: IPCL obtained regulatory approval in April 2025 and was subsequently launched in September 2025 in Japan.
Q: What percentage of the survey subjects were aware of implantable contact lenses?: A: According to the survey results, more than 70% (72.8%) of the survey subjects were aware of this treatment method.